Semaglutide is also associated with favorable changes to lipid metabolism, the process of fats being broken down and stored for energy
In future, once data are available on a larger number of patients switching treatments, the use of administrative claims data in similar analyses would help to increase confidence that the patients represented are those who have collected and adhered to treatment following switching
There is no FDA-approved indication for any patient population
Skipped periods A 2023 research review mentioned that losing 10%--15% of your body weight in a short period of time can cause amenorrhea , the medical term for missed periods
Over the course of several weeks, as you continue with your treatment, these effects become more pronounced, helping you feel fuller for longer periods and reducing overall calorie consumption
Texas Diabetes & Endocrinology notes that GLP-1 agonists can reduce thirst cues as well as appetite, which makes it easier to go outside under-hydrated